In the present study, TRAF6 expression in AML minimally affected inflammatory and immune-related gene expression (Fig. 2A), suggesting that TRAF6 expression has a differential impact on the gene expression profiles between AML and MDS. The gene discussed is TRAF6; the disease is myelodysplastic syndrome.